Today: 21 May 2026
Browse Category

Growth Stocks 4 November 2025 - 8 December 2025

ANET Stock Forecast: Why Analysts Still See Big Upside for Arista Networks After Its Latest Pullback

ANET Stock Forecast: Why Analysts Still See Big Upside for Arista Networks After Its Latest Pullback

Arista Networks shares closed near $129, down about 22% from their 52-week high but more than double their 52-week low. Q3 2025 revenue rose 27.5% year-over-year to $2.31 billion, with earnings beating estimates. Management projects Q4 revenue of $2.3–2.4 billion. Analysts maintain a bullish outlook, with a median price target near $167.50 and no “Sell” ratings.
7 December 2025
···
Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Stock (UPST) in December 2025: Can the AI Lender Turn Explosive Growth Into Sustainable Gains?

Upstart Holdings shares closed near $46.75 on December 7, 2025, valuing the AI lender at over $4 billion amid sharp volatility and short interest above 20%. The stock is down about 35% year-to-date despite a return to GAAP profitability and accelerated revenue growth. Recent technical signals remain mixed, with some trends turning bullish but overall models still rating UPST a “Sell.”
7 December 2025
···
SoFi Stock Tumbles After New $1.5 Billion Share Offering – Dilution Fears Clash With 2025 Growth Story

SoFi Stock Tumbles After New $1.5 Billion Share Offering – Dilution Fears Clash With 2025 Growth Story

SoFi Technologies announced a $1.5 billion underwritten public offering of common stock on December 4, sending shares down about 5–6% in after-hours trading. The new shares are priced at $27.50–$28.50, up to 7% below the prior close. All shares will be sold by the company, with an option for underwriters to buy 15% more. SoFi recently reported record Q3 results and raised its 2025 outlook.
5 December 2025
··
Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast, Inc. traded at $35.17 per share with a market cap of $20.68 billion in early December 2025. JPMorgan upgraded the stock to Overweight with a $43 target on December 4, while UBS reiterated a Buy rating and $50 target the same day. BNP Paribas Exane raised its rating to Outperform with a $40 target on December 1. The stock’s valuation remains high, with a trailing P/E in the high-70s to low-80s.
4 December 2025
····
MercadoLibre Stock News Today (November 29, 2025): Hedge Funds Shuffle, Analysts Stay Bullish, Growth Story Intact

MercadoLibre Stock News Today (November 29, 2025): Hedge Funds Shuffle, Analysts Stay Bullish, Growth Story Intact

MercadoLibre shares closed at $2,082 on November 28, giving the company a $105.5 billion market cap. The stock is up 22% year to date but down 9% in the past month and 16% over three months. Institutional investors disclosed major position changes, and analysts’ average 12-month price target is $2,850. Recent volatility follows strong revenue growth but weaker margins and earnings misses.
29 November 2025
··
Nu Holdings (NU) Stock Today, November 26, 2025: Fresh All‑Time High, Big Money Moves and Q3 Momentum

Nu Holdings (NU) Stock Today, November 26, 2025: Fresh All‑Time High, Big Money Moves and Q3 Momentum

Nu Holdings shares climbed 3.7% to about $17.23 by mid-session Wednesday, setting a new all-time high and extending a 66% year-to-date rally. The move follows strong Q3 earnings and price target hikes from KeyBanc, Morgan Stanley, and BofA. One major fund cut its stake while another increased exposure. Analysts continue to debate valuation as the stock outpaces fintech peers.
26 November 2025
···
SoFi Technologies (SOFI) Stock News Today – November 23, 2025: Crypto Push, Record Growth and Fresh Institutional Moves

SoFi Technologies (SOFI) Stock News Today – November 23, 2025: Crypto Push, Record Growth and Fresh Institutional Moves

SoFi Technologies closed at $25.19 Friday, valuing the company near $30.4 billion after a volatile year that saw shares hit an all-time high of $32.73 on Nov. 12. The stock is down about 11% this month but remains up 70% over 12 months and more than 400% in three years. A Motley Fool column questioned further upside after the rally. MarketBeat highlighted institutional moves and insider selling.
23 November 2025
···
Uber Stock Today, November 22, 2025: Can Surging Growth Justify the Latest Pullback in UBER Shares?

Uber Stock Today, November 22, 2025: Can Surging Growth Justify the Latest Pullback in UBER Shares?

Uber shares closed at $83.87 on November 21, down about 18% from their 52-week high of $101.99 reached in September. The stock saw heavy selling this week, dropping more than 5% intraday Thursday and trading on double its usual volume. This comes despite Uber reporting record Q3 growth, with revenue up 20% year over year and net income boosted by one-time gains.
22 November 2025
·
MercadoLibre (MELI) Stock Today, November 21, 2025: Volatile Price Action, Big 13F Moves and a High-Growth Fintech Story

MercadoLibre (MELI) Stock Today, November 21, 2025: Volatile Price Action, Big 13F Moves and a High-Growth Fintech Story

MercadoLibre shares fell 8.5% to $1,899.75 on Thursday, swinging over 11% intraday as hedge funds shifted positions, according to new 13F filings. Q3 revenue rose 39% to $7.4 billion, but margins narrowed and EPS missed estimates. Institutional ownership remains near 88%. After-hours trading showed a slight rebound to $1,908.99.
21 November 2025
···
Nu Holdings (NU) Stock Today, November 19, 2025: Price Action, Q3 Earnings Beat, Analyst Upgrades and Growth Outlook

Nu Holdings (NU) Stock Today, November 19, 2025: Price Action, Q3 Earnings Beat, Analyst Upgrades and Growth Outlook

Nu Holdings shares traded around $15.4–$15.5 on Wednesday, up 1% from Tuesday’s close and about 6% below the 52-week high of $16.55. The stock has surged 266% over three years and nearly 49% year-to-date. Recent record Q3 profits and analyst upgrades continue to drive trading, though no new company filings were released Wednesday. Market cap stands in the mid-$70 billion range.
19 November 2025
···
Uber Stock Skyrockets on Earnings Beat – Is the Rideshare Giant Set to Keep Surging?

Uber Stock Today, November 14, 2025: Price Action, Fresh Analyst Calls, Insider Selling and New Growth Catalysts

Uber shares traded around $92 Friday afternoon, up 0.2% despite a recent post-earnings decline. Goldman Sachs raised its price target on Uber to $126 after Q3 results, citing strong growth in bookings and adjusted EBITDA. Intraday volume reached about 8.3 million shares. Uber’s market cap stands near $190 billion, with year-to-date gains of roughly 53%.
14 November 2025
··
Amaze Holdings (AMZE) Completes The Food Channel Acquisition; Plans Platform Revamp for Culinary Creators — Nov 12, 2025

Amaze Holdings (AMZE) Soars on Q3 2025 Earnings as Revenue Jumps 1,884% and Creator-Commerce Strategy Accelerates

Amaze Holdings reported Q3 2025 revenue of $1.25 million, up 1,884% from a year earlier, but posted a net loss of $5.15 million as expenses surged. The stock jumped over 50% intraday on heavy trading. Gross merchandise value reached $2.7 million, with about 12.2 million active creator storefronts and more than 350 million total visitors. The company ended the quarter with $0.3 million in cash, later raising $9.2 million.
14 November 2025
··
Record Highs, $55 B Deals & Data Drama: Wall Street’s Wild Week (Oct 4–5, 2025)

7 Best Stocks to Buy Now for Big Gains (November 2025 Edition)

The S&P 500 is up about 16% and the Nasdaq 22% in 2025, both near record highs, but Wall Street CEOs warn a 10–15% correction is possible within two years. Nvidia became the first $5 trillion company as AI drives tech gains, while Apple and Microsoft each topped $4 trillion. European stocks have outperformed the U.S. this year. Markets may see volatility in the next six months amid policy and geopolitical uncertainty.
4 November 2025
·······
1 2 3

Stock Market Today

  • Australia Shares Set to Rise at Open, New Zealand Markets Dip
    May 20, 2026, 7:49 PM EDT. Australian shares are expected to open higher, signaling investor confidence in the region's market outlook. In contrast, New Zealand equities are projected to decline at the open, reflecting differing economic or market responses. Market data sourced from ICE Data Services with reference information provided by FactSet, supported by multiple financial data providers. The divergence underscores the varied regional market trends in Oceania at the start of the trading session.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop